Joshi, Parag H.

Friedewald-estimated versus directly measured low-density lipoprotein cholesterol and treatment implications

Martin, S. S., Blaha, M. J., Elshazly, M. B., Brinton, E. A., Toth, P. P., McEvoy, J. W., Joshi, P. H., Kulkarni, K. R., Mize, P. D., Kwiterovich, P. O., et al. (2013) · Journal of the American College of Cardiology

Lipoproteins and Cardiovascular HealthDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 428

Coronary Atherosclerosis Imaging by Coronary CT Angiography

Voros, S., Rinehart, S., Qian, Z., Joshi, P., Vazquez, G., Fischer, C., Belur, P., Hulten, E., & Villines, T. C. (2011) · JACC: Cardiovascular Imaging

Cardiac Imaging and DiagnosticsCoronary Interventions and Diagnostics

Cited by 362

Effects of liraglutide on visceral and ectopic fat in adults with overweight and obesity at high cardiovascular risk: a randomised, double-blind, placebo-controlled, clinical trial

Neeland, I. J., Marso, S. P., Ayers, C. R., Lewis, B., Oslica, R., Francis, W., Rodder, S., Pandey, A., & Joshi, P. H. (2021) · The Lancet Diabetes & Endocrinology

Pharmacology and Obesity TreatmentDiabetes Treatment and Management

Cited by 202

Remnant lipoprotein cholesterol and incident coronary heart disease: the Jackson Heart and Framingham offspring cohort studies

Joshi, P. H., Khokhar, A. A., Massaro, J. M., Lirette, S. T., Griswold, M. E., Martin, S. S., Blaha, M. J., Kulkarni, K. R., Correa, A., D'Agostino, R. B., et al. (2016) · Journal of the American Heart Association

Lipoproteins and Cardiovascular HealthDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 177

Apolipoprotein B, Residual Cardiovascular Risk After Acute Coronary Syndrome, and Effects of Alirocumab

Hagström, E., Steg, P. G., Szarek, M., Bhatt, D. L., Bittner, V. A., Danchin, N., Diaz, R., Goodman, S. G., Harrington, R. A., Jukema, J. W., et al. (2022) · Circulation

Lipoproteins and Cardiovascular HealthAcute Myocardial Infarction Research

Cited by 118

Effect of liraglutide on thigh muscle fat and muscle composition in adults with overweight or obesity: Results from a randomized clinical trial

Pandey, A., Patel, K. V., Segar, M. W., Ayers, C., Linge, J., Leinhard, O. D., Anker, S. D., Butler, J., Verma, S., Joshi, P. H., et al. (2024) · Journal of Cachexia, Sarcopenia and Muscle

Diabetes Treatment and ManagementPharmacology and Obesity Treatment

Cited by 80

Non–High-Density Lipoprotein Cholesterol, Guideline Targets, and Population Percentiles for Secondary Prevention in 1.3 Million Adults

Elshazly, M. B., Martin, S. S., Blaha, M. J., Joshi, P. H., Toth, P. P., McEvoy, J. W., Al-Hijji, M. A., Kulkarni, K. R., Kwiterovich, P. O., Blumenthal, R. S., et al. (2013) · Journal of the American College of Cardiology

Lipoproteins and Cardiovascular HealthDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 68

CAC for Risk Stratification Among Individuals With Hypertriglyceridemia Free of Clinical Atherosclerotic Cardiovascular Disease

Cainzos-Achirica, M., Quispe, R., Dudum, R., Greenland, P., Lloyd-Jones, D., Rana, J. S., Lima, J. A. C., Doria de Vasconcellos, H., Joshi, P. H., Khera, A., et al. (2022) · JACC: Cardiovascular Imaging

Cardiac Imaging and DiagnosticsLipoproteins and Cardiovascular Health

Cited by 24

Measurement and Application of Incidentally Detected Coronary Calcium

Parsa, S., Saleh, A., Raygor, V., Hoeting, N., Rao, A., Navar, A. M., Rohatgi, A., Kay, F., Abbara, S., Khera, A., et al. (2024) · Journal of the American College of Cardiology

Cardiac Imaging and DiagnosticsHealth Promotion and Cardiovascular Prevention

Cited by 23

Identification of allele-specific KIV-2 repeats and impact on Lp(a) measurements for cardiovascular disease risk

Behera, S., Belyeu, J. R., Chen, X., Paulin, L. F., Nguyen, N. Q. H., Newman, E., Mahmoud, M., Menon, V. K., Qi, Q., Joshi, P., et al. (2023) · BMC Medical Genomics

Lipoproteins and Cardiovascular HealthGenomic variations and chromosomal abnormalities

Cited by 21